Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yan Wang, Huijie Qi, Tianxiao Wang, Wenxin Zhang, Xiaojin Shi, Qiong Zhan, Qunyi Li & Mingkang Zhong. (2023) STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy. Journal of Chemotherapy 0:0, pages 1-11.
Read now
Read now
Parker J. Funk, Patrick O. Perche, Rohan Singh, Katherine A. Kelly & Steven R. Feldman. (2022) Comparing available JAK inhibitors for treating patients with psoriasis. Expert Review of Clinical Immunology 18:3, pages 281-294.
Read now
Read now
Mohammad I. Fardos, Rohan Singh, Patrick O. Perche, Katherine A. Kelly & Steven R. Feldman. (2022) Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis. Expert Review of Clinical Immunology 18:3, pages 221-231.
Read now
Read now
Evgeniya Petrova & Alain Hovnanian. (2020) Advances in understanding of Netherton syndrome and therapeutic implications. Expert Opinion on Orphan Drugs 8:11, pages 455-487.
Read now
Read now
Erika L. Crowley, Novin Nezamololama, Kim Papp & Melinda J. Gooderham. (2020) Abrocitinib for the treatment of atopic dermatitis. Expert Review of Clinical Immunology 16:10, pages 955-962.
Read now
Read now
Francesco Bellinato, Paolo Gisondi & Giampiero Girolomoni. (2020) A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis. Expert Review of Clinical Pharmacology 13:5, pages 481-491.
Read now
Read now
Karen Ly, Kristen M Beck, Mary P Smith, Ana-Maria Orbai & Wilson Liao. (2019) Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. Psoriasis: Targets and Therapy 9, pages 97-107.
Read now
Read now
Articles from other publishers (28)
Jia Guo, Hanyi Zhang, Wenri Lin, Lixia Lu, Juan Su & Xiang Chen. (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Jundong Huang & Wei Shi. (2023) Successful treatment of nail lichen planus with tofacitinib: a case report and review of the literature. Frontiers in Medicine 10.
Crossref
Crossref
Mengjie Li, Benjin Chen, Lingling Xu, Yu Wang, Zhu Chen, Bingyan Ma, Shichun Qin, Yechun Jiang, Cheng Gu, Haisheng Qian & Fengli Xiao. (2023) Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Weiwei Jiang, Xiuliang Ma, Tao Guo, Mengmeng Song & Junling Zhang. (2023) Abrocitinib‐A promising option for patients with refractory bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Chunxiao Li, Yu Xu, Tengjiao Gao, Shunyao Zhang, Zhe Lin, Shaobo Gu, Yi Fang, Xin Yuan, Siyi Yu, Qi Jiang, Zhongze Lou, Xiuming Zhang, Jie Zhang, Qiaoyan Wu, Mengli Gu, Xiaoyun Ding, Jing Sun & Yi Chen. (2023) Ruxolitinib Alleviates Inflammation, Apoptosis, and Intestinal Barrier Leakage in Ulcerative Colitis via STAT3. Inflammatory Bowel Diseases 29:8, pages 1191-1201.
Crossref
Crossref
Shiva Tushir, Monu Yadav, Anil Kumar & Kajal Joshi. 2023. Drug Repurposing for Emerging Infectious Diseases and Cancer. Drug Repurposing for Emerging Infectious Diseases and Cancer
569
592
.
Yizhou Jiang, Limor Rubin, Zhiwei Zhou, Haibo Zhang, Qiaozhu Su, Sheng-Tao Hou, Philip Lazarovici & Wenhua Zheng. (2022) Pharmacological therapies and drug development targeting SARS-CoV-2 infection. Cytokine & Growth Factor Reviews 68, pages 13-24.
Crossref
Crossref
Xiangjie Chen, Qiuyu Wu, Xinhua Cao, Yunshan Yang, Zheng Gong, Tengfei Ren, Qian Du, Yukang Yuan, Yibo Zuo, Ying Miao, Jiuyi He, Caixia Qiao, Zhijin Zheng, Tingting Zhang, Yang Xu, Depei Wu, Qiao Wang, Lin Huang, Zhijun Xie, Haitao Lv, Jun Wang, Fangyuan Gong, Zhichun Liu, Chengping Wen & Hui Zheng. (2022) Menthone inhibits type-I interferon signaling by promoting Tyk2 ubiquitination to relieve local inflammation of rheumatoid arthritis. International Immunopharmacology 112, pages 109228.
Crossref
Crossref
Yasamin Kalantari, Sara Sadeghi, Delaram Asadi & Azadeh Goodarzi. (2022) A literature review on Janus kinase (JAK) inhibitors for the treatment of immunobullous disorders. International Immunopharmacology 110, pages 108923.
Crossref
Crossref
Liping Wu, Bin Tian, Mingshu Wang, Anchun Cheng, Renyong Jia, Dekang Zhu, Mafeng Liu, Qiao Yang, Ying Wu, Juan Huang, XinXin Zhao, Shun Chen, Shaqiu Zhang, Xumin Ou, Sai Mao, Qun Gao, Di Sun, Yanling Yu, Ling Zhang & LeiCHang Pan. (2022) Duck Plague Virus Negatively Regulates IFN Signaling to Promote Virus Proliferation via JNK Signaling Pathway. Frontiers in Immunology 13.
Crossref
Crossref
Angela Yen Moore, Tyler Cepica & Samanna Maberry. (2022) Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib. JAAD Case Reports 23, pages 64-66.
Crossref
Crossref
Vladimir V. Sobolev, Anna G. Soboleva, Elena V. Denisova, Eva A. Pechatnikova, Eugenia Dvoryankova, Irina M. Korsunskaya & Alexandre Mezentsev. (2022) Proteomic Studies of Psoriasis. Biomedicines 10:3, pages 619.
Crossref
Crossref
Kristin Knoke, Robert R. Rongisch, Katarzyna M. Grzes, Roman Schwarz, Beate Lorenz, Nir Yogev, Erika L. Pearce, Edward J. Pearce, David M. Kofler & Mario Fabri. (2022) Tofacitinib Suppresses IL-10/IL-10R Signaling and Modulates Host Defense Responses in Human Macrophages. Journal of Investigative Dermatology 142:3, pages 559-570.e6.
Crossref
Crossref
Christine E. Jo, Melinda Gooderham & Jennifer Beecker. (2021) TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors. International Journal of Dermatology 61:2, pages 139-147.
Crossref
Crossref
L. Cornaghi, N. Gagliano, F.W. Baruffaldi Preis, F. Prignano & E. Donetti. (2022) Inside-out and outside-in organotypic normal human skin culture: JAK-STAT pathway is activated after pro-inflammatory psoriatic cytokine exposure. Tissue and Cell 74, pages 101675.
Crossref
Crossref
Sara Malik & Philip R Cohen. (2021) Vitiligo-Associated Autoimmune Disorders: A Woman With Vitiligo and Incipient Hypothyroidism. Cureus.
Crossref
Crossref
Shuying Zhou, Fei Qi, Yue Gong, Jinping Zhang & Binghua Zhu. (2021) Biological Therapies for Atopic Dermatitis: A Systematic Review. Dermatology 237:4, pages 542-552.
Crossref
Crossref
B. Olabi, S. Worboys, T. Garland, D. J. C. Grindlay, N. K. Rogers & K. E. Harman. (2020) What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies. Clinical and Experimental Dermatology 45:8, pages 980-985.
Crossref
Crossref
F. Tasker, A. Brown, D. J. C. Grindlay, N. K. Rogers & K. E. Harman. (2020) What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies. Clinical and Experimental Dermatology 45:8, pages 974-979.
Crossref
Crossref
Iain S. Haslam & Ralf Paus. (2020) The Hair Follicle as an Interdisciplinary Model for Biomedical Research: An Eclectic Literature Synthesis. BioEssays 42:11, pages 2000053.
Crossref
Crossref
Perrine Cochez, Mathilde Choteau, Nisha Limaye, Marie Baeck & Laure Dumoutier. (2020) Implication of T Helper Cytokines in Contact Dermatitis and Atopic Dermatitis. Current Treatment Options in Allergy 7:3, pages 258-273.
Crossref
Crossref
Sineida Berbert Ferreira, Rachel Berbert Ferreira & Morton Aaron Scheinberg. (2020) Topical tofacitinib in treatment of alopecia areata. Einstein (São Paulo) 18.
Crossref
Crossref
Melpone Komnitski, Angelo Komnitski, Amilton Komnitski Junior & Caio César Silva de Castro. (2020) Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation. Anais Brasileiros de Dermatologia 95:4, pages 473-476.
Crossref
Crossref
Sobia Ahsan Halim, Ajmal Khan, Rene Csuk, Ahmed Al-Rawahi & Ahmed Al-Harrasi. (2020) Diterpenoids and Triterpenoids From Frankincense Are Excellent Anti-psoriatic Agents: An in silico Approach. Frontiers in Chemistry 8.
Crossref
Crossref
Pengfei Xu, Pei Shen, Bin Yu, Xi Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li & JuBo Wang. (2020) Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry 192, pages 112155.
Crossref
Crossref
Xumin Hu, Jianhua Tang, Xuyun Hu, Peng Bao, Weixi Deng, Jionglin Wu, Yuwei Liang, Zhipeng Chen, Liangbin Gao & Yong Tang. (2020) Silencing of Long Non-coding RNA HOTTIP Reduces Inflammation in Rheumatoid Arthritis by Demethylation of SFRP1. Molecular Therapy - Nucleic Acids 19, pages 468-481.
Crossref
Crossref
E. L. NasonovA. S. Avdeeva. (2019) IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE. Rheumatology Science and Practice 57:4, pages 452-461.
Crossref
Crossref
Jacqueline McKesey & Amit G. Pandya. (2019) A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo. Journal of the American Academy of Dermatology 81:2, pages 646-648.
Crossref
Crossref